Jan Lewerenz Selected Research

Jan Lewerenz Research Topics

Disease

10	Autoimmune Diseases of the Nervous System 02/2024 - 01/2018
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2024 - 09/2015
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 04/2013
5	Neoplasms (Cancer) 01/2024 - 06/2014
5	Seizures (Absence Seizure) 01/2023 - 07/2012
5	Multiple Sclerosis 01/2023 - 01/2013
5	Huntington Disease (Huntington's Disease) 01/2023 - 01/2020
5	Disease Progression 01/2023 - 01/2013
5	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 07/2012
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2024 - 10/2009
4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2009
4	Parkinson Disease (Parkinson's Disease) 09/2022 - 08/2006
4	Brain Ischemia (Cerebral Ischemia) 05/2012 - 01/2003
3	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 04/2015
3	Epilepsy (Aura) 01/2023 - 06/2014
3	Movement Disorders (Movement Disorder) 01/2023 - 07/2012
3	Neuroinflammatory Diseases 01/2023 - 12/2015
3	Glioma (Gliomas) 11/2022 - 01/2018
3	Leukocytosis (Pleocytosis) 01/2022 - 04/2015
2	Diabetes Mellitus 05/2024 - 02/2024
2	Pain (Aches) 02/2024 - 01/2023
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 12/2015
2	Sleep Wake Disorders 01/2023 - 05/2017
2	Ataxia (Dyssynergia) 01/2023 - 01/2023
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023 - 01/2023
2	Cognitive Dysfunction 01/2023 - 05/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 04/2014
2	Inflammation (Inflammations) 01/2022 - 11/2021
2	Parasomnias (Parasomnia) 05/2017 - 06/2014
2	Infarction (Infarctions) 05/2012 - 04/2010
2	Reperfusion Injury 05/2012 - 09/2009
2	Stroke (Strokes) 05/2012 - 09/2009
1	Neurologic Manifestations (Neurological Manifestations) 03/2024
1	Thrombotic Microangiopathies 03/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2024
1	Back Pain (Backache) 02/2024
1	Chronic Pain 02/2024
1	Myoclonus (Nocturnal Myoclonus) 01/2023
1	Facial Paralysis (Facial Palsy) 01/2023
1	Tremor (Tremors) 01/2023
1	Cerebellar Ataxia (Dysmetria) 01/2023
1	Gliosis 01/2023
1	Tension-Type Headache (Tension Headache) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Atrophy 09/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	COVID-19 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021
1	Infections 11/2021
1	Central Nervous System Infections (Central Nervous System Infection) 11/2021
1	Sepsis (Septicemia) 01/2019
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 01/2024 - 07/2012
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2022 - 07/2012
6	Immunoglobulin G (IgG)IBA 02/2024 - 04/2015
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2017
6	AutoantibodiesIBA 02/2024 - 09/2015
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2016
6	Glutamic Acid (Glutamate)FDA Link 12/2015 - 10/2009
6	Glutathione (Reduced Glutathione)IBA 06/2014 - 08/2006
5	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2024 - 11/2021
4	Leucine (L-Leucine)FDA Link 11/2022 - 01/2018
3	IronIBA 01/2023 - 01/2018
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 05/2017
3	Peptides (Polypeptides)IBA 09/2022 - 01/2009
3	CytokinesIBA 01/2022 - 12/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2015 - 04/2013
3	Cystine (L-Cystine)IBA 06/2014 - 04/2010
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 03/2024 - 01/2023
2	anti-CASPR2 autoantibodyIBA 02/2024 - 01/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 04/2017
2	C-Reactive ProteinIBA 01/2024 - 04/2017
2	preproenkephalinIBA 09/2022 - 01/2021
2	Oligoclonal BandsIBA 01/2022 - 01/2019
2	Immunoglobulin M (IgM)IBA 01/2020 - 04/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2019 - 01/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 01/2017
2	AntiportersIBA 06/2014 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 07/2012 - 01/2003
1	AlbuminsIBA 05/2024
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	proenkephalinIBA 09/2022
1	gamma-Aminobutyric Acid (GABA)IBA 02/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2022
1	dimemorfan (AT 17)IBA 01/2022
1	N-Methylaspartate (NMDA)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Rituximab (Mabthera)FDA Link 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019

Therapy/Procedure

4	Immunotherapy 01/2023 - 08/2021
3	Therapeutics 01/2021 - 08/2006
1	Stem Cell Transplantation 03/2024
1	Transplantation 03/2024
1	Tracheostomy 01/2019